EVPL and atherosclerosis: Whereas immunization of hypercholesterolemic mice with MDA-p210 has been shown to induce antigen-specific antibodies and reduce atherosclerotic plaque formation10, immunization studies using native p210 inhibit the development of atherosclerosis without induction of p210 autoantibodies11–13.